Saf Health Work.  2018 Mar;9(1):84-94. 10.1016/j.shaw.2017.06.012.

Chemical Risk Assessment Screening Tool of a Global Chemical Company

Affiliations
  • 1ES4chem, Bennekom, The Netherlands.
  • 2Solvay, HSE, Industrial Hygiene Corporate, Lyon, France. christophe.rochin@solvay.com
  • 3O-I Manufacturing, Wingles, France.

Abstract

BACKGROUND
This paper describes a simple-to-use and reliable screening tool called Critical Task Exposure Screening (CTES), developed by a chemical company. The tool assesses if the exposure to a chemical for a task is likely to be within acceptable levels.
METHODS
CTES is a Microsoft Excel tool, where the inhalation risk score is calculated by relating the exposure estimate to the corresponding occupational exposure limit (OEL) or occupational exposure band (OEB). The inhalation exposure is estimated for tasks by preassigned ART1.5 activity classes and modifying factors.
RESULTS
CTES requires few inputs. The toxicological data, including OELs, OEBs, and vapor pressure are read from a database. Once the substance is selected, the user specifies its concentration and then chooses the task description and its duration. CTES has three outputs that may trigger follow-up: (1) inhalation risk score; (2) identification of the skin hazard with the skin warnings for local and systemic adverse effects; and (3) status for carcinogenic, mutagenic, or reprotoxic effects.
CONCLUSION
The tool provides an effective way to rapidly screen low-concern tasks, and quickly identifies certain tasks involving substances that will need further review with, nevertheless, the appropriate conservatism. This tool shows that the higher-tier ART1.5 inhalation exposure assessment model can be included effectively in a screening tool. After 2 years of worldwide extensive use within the company, CTES is well perceived by the users, including the shop floor management, and it fulfills its target of screening tool.

Keyword

occupational exposure; risk assessment; risk management
Full Text Links
  • SHAW
Share
  • Twitter
  • Facebook
Copyright © 2020 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr